Emerging Therapies in Lung Cancer: A Review on Targeted and Immune Based Interventions.

Tagrisso (osimertinib) - AstraZeneca

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Lorbrena (lorlatinib) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42708310

E Bhargav; K C Geervani; Kalpi Sania Kausar; Mulla Shaikshavali; Penugonda Shivarani; Repollu Maddileti; Teleke Kumar Swamy

Sep 9, 2026